SPINEGUARD SA (ALSGD.PA) Stock Price, Forecast & Analysis
Europe - EPA:ALSGD - FR0011464452 - Common Stock
ALSGD.PA Key Statistics, Chart & Performance
The current stock price of ALSGD.PA is 0.1376 EUR. In the past month the price increased by 0.15%. In the past year, price decreased by -32.88%.
ALSGD.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.3 | 111.94B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 18.38 | 49.34B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 21.73 | 46.58B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.31 | 22.61B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.23 | 22.50B | ||
| BIM.PA | BIOMERIEUX | 27.42 | 12.53B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.87 | 3.80B | ||
| DIA.MI | DIASORIN SPA | 16.95 | 3.29B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.54 | 1.28B | ||
| DRW8.DE | DRAEGERWERK AG | 9.58 | 1.16B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.2 | 982.02M | ||
| ELN.MI | EL.EN. SPA | 18.28 | 938.69M |
Related stock screener links
About ALSGD.PA
Company Profile
Spineguard SA engages in the design and manufacture of medical devices for the spine. The company is headquartered in Vincennes, Ile-De-France and currently employs 15 full-time employees. The company went IPO on 2013-04-29. The firm involves with the DSG (Dynamic Surgical Guidance) technology that concentrates on the placement of bone implants for the benefit of patients, surgeons, hospital staff, and healthcare systems. The DSG digital technology platform is a real-time surgical guidance work based on the measurement of local electrical conductivity of tissues without X-rays that includes PediGuard devices, the manual instruments capable of alerting surgeons in real time to potential pedicle or vertebral breaches. The technology is also implemented for the surgical robots to improve the safety, accuracy and autonomy.
Company Info
SPINEGUARD SA
10, Cours Louis Lumiere
Vincennes ILE-DE-FRANCE FR
Employees: 24
Phone: 33145184519
SPINEGUARD SA / ALSGD.PA FAQ
Can you describe the business of SPINEGUARD SA?
Spineguard SA engages in the design and manufacture of medical devices for the spine. The company is headquartered in Vincennes, Ile-De-France and currently employs 15 full-time employees. The company went IPO on 2013-04-29. The firm involves with the DSG (Dynamic Surgical Guidance) technology that concentrates on the placement of bone implants for the benefit of patients, surgeons, hospital staff, and healthcare systems. The DSG digital technology platform is a real-time surgical guidance work based on the measurement of local electrical conductivity of tissues without X-rays that includes PediGuard devices, the manual instruments capable of alerting surgeons in real time to potential pedicle or vertebral breaches. The technology is also implemented for the surgical robots to improve the safety, accuracy and autonomy.
Can you provide the latest stock price for SPINEGUARD SA?
The current stock price of ALSGD.PA is 0.1376 EUR. The price increased by 3.61% in the last trading session.
What is the dividend status of SPINEGUARD SA?
ALSGD.PA does not pay a dividend.
How is the ChartMill rating for SPINEGUARD SA?
ALSGD.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the analyst forecast for ALSGD.PA stock?
9 analysts have analysed ALSGD.PA and the average price target is 0.64 EUR. This implies a price increase of 367.01% is expected in the next year compared to the current price of 0.1376.
Can you provide the upcoming earnings date for SPINEGUARD SA?
SPINEGUARD SA (ALSGD.PA) will report earnings on 2026-04-13.
ALSGD.PA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to ALSGD.PA. When comparing the yearly performance of all stocks, ALSGD.PA turns out to be only a medium performer in the overall market: it outperformed 65.28% of all stocks.
ALSGD.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALSGD.PA. ALSGD.PA may be in some trouble as it scores bad on both profitability and health.
ALSGD.PA Financial Highlights
Over the last trailing twelve months ALSGD.PA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 47.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.69% | ||
| ROE | -59.82% | ||
| Debt/Equity | 0.34 |
ALSGD.PA Forecast & Estimates
9 analysts have analysed ALSGD.PA and the average price target is 0.64 EUR. This implies a price increase of 367.01% is expected in the next year compared to the current price of 0.1376.
For the next year, analysts expect an EPS growth of 83.22% and a revenue growth -15.4% for ALSGD.PA